DBV Technologies (DBVT) EBITDA Margin (2018 - 2026)
DBV Technologies (DBVT) posted EBITDA Margin of -4012.50% for Q3 2026, down 2816.07 percentage points from -1196.43% a year earlier but up 3130.36 percentage points from the prior quarter.
Powered by 
Analysis
DBV Technologies (DBVT) EBITDA Margin (2018 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA Margin at DBV Technologies was -5358.76%, down 3190.51 percentage points year-over-year; for FY2025, it was -2552.56%, up 245.40 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -1236.65 percentage points (FY2020 to FY2025).
- In prior years, DBV Technologies' EBITDA Margin was -2797.95% in FY2024 (-2222.99 pp), -574.96% in FY2023 (+1148.18 pp), -1723.14% in FY2022 (-142.24 pp) and -1580.90% in FY2021 (-265.00 pp).
- Quarterly EBITDA Margin has run from a low of -7142.86% in Q2 2026 to a high of -257.42% in Q4 2023 over five years.
- On a year-over-year basis, EBITDA Margin has declined in each of the last four quarters, with an average year-over-year change of -1898.14 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2025, with a gain of 1646.86 percentage points; the weakest was Q2 2026, with a drop of 4449.52 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -7142.86% (Q2 2026), -5222.22% (Q1 2026) and -6975.16% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | DBV Technologies | 1.04 Bn | 274.26 Mn | - | -4,012.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -4,012.50% |
| Jun 30, 2026 | -7,142.86% |
| Mar 31, 2026 | -5,222.22% |
| Dec 31, 2025 | -6,975.16% |
| Sep 30, 2025 | -1,196.43% |
| Jun 30, 2025 | -2,693.33% |
| Mar 31, 2025 | -3,200.00% |
| Dec 31, 2024 | -4,146.96% |
| Sep 30, 2024 | -2,843.28% |
| Jun 30, 2024 | -3,041.00% |
| Mar 31, 2024 | -2,025.94% |
| Dec 31, 2023 | -257.42% |
| Sep 30, 2023 | -915.30% |
| Jun 30, 2023 | -1,069.89% |
| Mar 31, 2023 | -975.07% |
| Sep 30, 2022 | -874.11% |
| Jun 30, 2022 | -1,437.21% |
| Mar 31, 2022 | -682.25% |
| Dec 31, 2021 | -504.98% |
| Sep 30, 2021 | -1,759.79% |
API Access
DBV Technologies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DBVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "DBVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DBVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();